Akouos (NASDAQ:AKUS) – FDA Clears Akouos’ Gene Therapy Trial For Genetic Form Of Hearing Loss
The FDA has signed off Akouos Inc’s AKUS Investigational New Drug application to initiate a Phase 1/2 trial of AK-OTOF, gene therapy for otoferlin gene (OTOF)-mediated hearing loss. OTOF-mediated hearing loss…